What was the Indian Supreme Court's rationale for upholding the rejection of Novartis' patent in the Novartis AG v. Union of India & Others (2013) case?
The court believed that Novartis did not have a valid patent claim.
The modifications to the drug did not enhance its therapeutic efficacy significantly.
The modifications to the drug did not enhance its therapeutic efficacy significantly.
Novartis was charging excessively high prices for the drug.
The Indian Supreme Court upheld the rejection of Novartis' patent because the modifications to the drug did not enhance its therapeutic efficacy significantly enough to warrant a new patent.hence option b is correct.